| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 1.53 MB | Adobe PDF |
Advisor(s)
Abstract(s)
Next-generation sequencing has revolutionized clinical diagnostic testing. Yet, for a substantial proportion of patients, sequence information restricted to exons and exon-intron boundaries fails to identify the genetic cause of the disease. Here we review evidence from mRNA analysis and entire genomic sequencing indicating that pathogenic mutations can occur deep within the introns of over 75 disease-associated genes. Deleterious DNA variants located more than 100 base pairs away from exon-intron junctions most commonly lead to pseudo-exon inclusion due to activation of non-canonical splice sites or changes in splicing regulatory elements. Additionally, deep intronic mutations can disrupt transcription regulatory motifs and non-coding RNA genes. This review aims to highlight the importance of studying variation in deep intronic sequence as a cause of monogenic disorders as well as hereditary cancer syndromes.
Description
© Springer-Verlag Berlin Heidelberg 2017
Keywords
Androgen Insensitivity Syndrome Duchenne Muscular Dystrophy Fabry Disease Splice enhancer Splice site
Pedagogical Context
Citation
Hum Genet. 2017 Sep;136(9):1093-1111
Publisher
Springer Nature